Clinical Trial Update: IgIV Plus Prednisone vs High-dose Dexamethasone for ITP [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravenous immunoglobulin plus prednisone against high-dose dexamethasone for immune thrombocytopenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• IgIV + prednisone
• high-dose dexamethasone

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Immune Thrombocytopenia (ITP) | Phase 3 | Status: RECRUITING